X4 Pharmaceuticals, Inc. Common Stock (XFOR)
X4 Pharmaceuticals, Inc. Common Stock (XFOR) has a 17-report earnings history dating back to Aug 03, 2021. Its average absolute post-earnings move is ±12.68%, and 35.3% of those reactions were positive. Its largest post-earnings gain was +32% (Mar 21, 2024) and its largest decline was -55.24% (Nov 13, 2024).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±12.68%
Positive %
35.3%
Negative %
64.7%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Nov 05, 2025 | ☀ PRE | $3.74 | $3.88 | $3.55 | 29,443 | -10.13% | open_in_new |
| May 01, 2025 | ☀ PRE | $4.00 | $4.03 | $3.79 | 6,517 | -11.46% | open_in_new |
| Mar 25, 2025 | ☀ PRE | $0.29 | $0.29 | $0.26 | 43,705 | -12.66% | open_in_new |
| Nov 13, 2024 | ☀ PRE | $0.49 | $0.50 | $0.27 | 131,997 | -55.24% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $0.68 | $0.69 | $0.66 | 16,898 | +3.79% | open_in_new |
| May 07, 2024 | ☀ PRE | $1.09 | $1.12 | $1.08 | 26,345 | -9.58% | open_in_new |
| Mar 21, 2024 | ☀ PRE | $1.05 | $1.32 | $1.32 | 195,712 | +32% | open_in_new |
| Nov 09, 2023 | ☀ PRE | $0.72 | $0.81 | $0.79 | 55,489 | +7.76% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $1.32 | $1.32 | $1.05 | 500,626 | -35.98% | open_in_new |
| May 04, 2023 | ☀ PRE | $1.47 | $1.62 | $1.54 | 71,283 | +6.21% | open_in_new |
| Mar 21, 2023 | ☀ PRE | $0.91 | $0.92 | $0.89 | 82,170 | +2.76% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $1.85 | $1.93 | $1.90 | 16,278 | -3.07% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $1.27 | $1.27 | $1.27 | 1,233 | -1.17% | open_in_new |
| May 12, 2022 | ☀ PRE | $1.05 | $1.07 | $1.02 | 7,288 | +1.49% | open_in_new |
| Mar 17, 2022 | ☀ PRE | $1.85 | $1.93 | $1.78 | 4,240 | -9.87% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $6.05 | $6.17 | $5.16 | 9,159 | -7.69% | open_in_new |
| Aug 03, 2021 | ☀ PRE | $5.99 | $5.99 | $5.64 | 4,410 | -4.73% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±12.68%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
4 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| EFFECT | 20260514 | open_in_new SEC.gov |
| 4 | 20260513 | open_in_new SEC.gov |
| 8-K/A | 20260513 | open_in_new SEC.gov |
Frequently asked about XFOR earnings
How much does XFOR stock move after earnings? expand_more
Over 17 reports, XFOR has moved an average of ±12.68% the session after earnings, closing higher 35.3% of the time.
What was XFOR's biggest post-earnings move? expand_more
XFOR's largest post-earnings gain on record was +32% on Mar 21, 2024, and its largest decline was -55.24% on Nov 13, 2024.
Where can I find X4 Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more
All of X4 Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right